| 12060553 |
Evolution of BoNT peptidases |
Michael S. Packer, Travis R. Blum, David R. Liu, Matthew Beard |
2024-08-13 |
|
| 11944688 |
Biologically active compounds |
Wouter Eilers, Adam James Reginald Gadd |
2024-04-02 |
|
| 11753633 |
Compositions and methods for treatment of pain |
R. John Collier, Isaac Chiu, Bradley L. Pentelute, Shilpa Palan, Sai Man Liu |
2023-09-12 |
|
| 11541124 |
Biologically active compound conjugated to a stapled or stitched peptide |
Wouter Eilers, Adam James Reginald Gadd |
2023-01-03 |
|
| 11248219 |
Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins |
Peter James, John Chaddock, Roger K. Aoki, Lance E. Steward, Joseph Francis |
2022-02-15 |
|
| 10744190 |
Method for suppressing spasmodic torticollis |
John Chaddock |
2020-08-18 |
|
| 10619146 |
Non-cytotoxic protein conjugates |
John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance E. Steward |
2020-04-14 |
|
| 10550377 |
Suppression of prostate cancer using a targeted clostridial neurotoxin |
Frederic Madec, Philip Lecane, Philip Marks |
2020-02-04 |
|
| 10240138 |
Polypeptides that bind to and inhibit secretion from growth hormone secreting cells |
Frederic Madec, Phil Lecane, Philip Marks |
2019-03-26 |
|
| 10226433 |
Use of cannabinoids in the treatment of degenerative skeletal muscle diseases |
Vincenzo Di Marzo, Colin Stott, Fabio Iannotti |
2019-03-12 |
|
| 10113159 |
Suppression of cancer |
Frederic Madec, Philip Lecane, Philip Marks |
2018-10-30 |
|
| 9849163 |
Modified non-cytotoxic proteases |
John Chaddock |
2017-12-26 |
|
| 9474807 |
Non-cytotoxic protein conjugates |
John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance E. Steward |
2016-10-25 |
|
| 9243301 |
Fusion proteins |
John Chaddock, Philip Marks, Patrick Stancombe, Kei Roger Aoki, Joseph Francis +1 more |
2016-01-26 |
|
| 9139635 |
Non-cytotoxic protein conjugates |
John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance E. Steward |
2015-09-22 |
|
| 9072736 |
Treatment of pain |
John Chaddock, Philip Marks, Patrick Stancombe, K. Roger Aoki, Joseph Francis +1 more |
2015-07-07 |
|
| 9012195 |
Non-cytotoxic protein conjugates |
John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance E. Steward |
2015-04-21 |
|
| 9006395 |
Recombinant toxin fragments |
Clifford Shone, John Chaddock, Philip Marks, J. Mark Sutton, Patrick Stancombe +1 more |
2015-04-14 |
|
| 8956847 |
Fusion proteins |
John Chaddock, Philip Marks, Patrick Stancombe, Lyndsey Durose |
2015-02-17 |
|
| 8940870 |
Fusion proteins |
John Chaddock, Philip Marks, Patrick Stancombe, Kei Roger Aoki, Joseph Francis +1 more |
2015-01-27 |
$216,923,000 |
| 8852603 |
Inhibition of secretion from non-neuronal cells |
John Chaddock, Conrad Padraig Quinn, John Robert PURKISS |
2014-10-07 |
|
| 8796216 |
Suppression of neuroendocrine diseases |
Stephen Johnstone, Philip Marks |
2014-08-05 |
|
| 8790897 |
Treatment of mucus hypersecretion |
Conrad Padraig Quinn, John Chaddock |
2014-07-29 |
|
| 8778634 |
Non-cytotoxic protein conjugates |
John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance E. Steward |
2014-07-15 |
$103,728,000 |
| 8603779 |
Non-cytotoxic protein conjugates |
John Chaddock, Charles Penn, Kei Roger Aoki, Joseph Francis, Lance E. Steward |
2013-12-10 |
$31,890,000 |
